|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02297 RAINMED-B
Nominal 
0.184 0.000 (0.000%) | 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Turnover | 39,824 | -45.610% | 73,219 | 83,604 | 81,199 | 6,097 |
| Cost of Sales | (15,957) | -35.308% | (24,666) | (13,780) | (12,167) | (837) |
| Gross Profit | 23,867 | -50.843% | 48,553 | 69,824 | 69,032 | 5,260 |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | (12,981) | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (5,856) | 6000.000% | (96) | (1,210,963) | (493,870) | (118,180) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (115,300) | -1.527% | (117,088) | (1,351,413) | (638,689) | (150,958) | |
| Taxation | (242) | -- | 22 | 5,450 | 5,043 | 5,718 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 2,046 | 65.534% | 1,236 | 0 | 1 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (113,496) | -2.015% | (115,830) | (1,345,963) | (633,645) | (145,240) | |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (2,995) | -73.008% | (11,096) | (2,735) | 2,047 | (22) |
| Depreciation & Amortisation | -- | -- | 22,237 | 16,662 | 10,863 | 2,349 |
| Directors' Emoluments | -- | -- | 11,962 | 25,552 | 66,416 | 546 |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | -10.000 | 0.000% | -10.000 | -150.000 | -99.000 | -- |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.106) | (0.124) | (0.113) | -- |
| NBV per share ($) | 0.349 | -- | 0.441 | 0.530 | -- | -- |
| Remarks: | Real time quote last updated: 22/04/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -113,496,000 |
| %Change | -2.015% |
| EPS / (LPS) | RMB -0.100 |
| NBV Per Share (¥) | RMB 0.349 |